Price $153.73 |
Market Cap
40.29B
|
Sector Health Care |
Div. Growth
8.00%
|
|
P/E
31.0
|
P/B
7.97
|
P/S
6.09
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
53.3
|
Op. Cash Flow
1.31M
|
FCF
2.5
|
|
Op. Margin
23.20%
|
Net Margin
19.90%
|
ROE
25.60%
|
ROI
14.70%
|
|
ROA
12.70%
|
EPS Growth
36.60%
|
Current Ratio
2.2
|
Debt/Equity
50.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LogicMark Inc (LGMK) | $0.62 | - | - | 7.3M | Strong Buy |
| Vericel Corp (VCEL) | $23.03 | - | - | 1.18B | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.90 | - | - | 12.9M | Strong Buy |
| Societal CDMO Inc (SCTL) | $1.30 | - | - | 85M | Strong Buy |
| Biomerica Inc (BMRA) | $3.74 | - | - | 41.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
